Gewählte Publikation:
Gratze, G; Fortin, J; Labugger, R; Binder, A; Kotanko, P; Timmermann, B; Luft, FC; Hoehe, MR; Skrabal, F.
beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.
Hypertension. 1999; 33(6):1425-1430
Doi: 10.1161/01.HYP.33.6.1425
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Binder Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Recent evidence suggests that the prodownregulatory Gly16 allele of the beta-2 adrenergic receptor (beta-2 AR) is associated with essential hypertension in African Caribbeans. To further investigate the effect of the glycine (Gly)16 and arginine (Arg)16 beta-2 AR variants on hemodynamics, we investigated the agonist-mediated in vivo vasodilation in normotensive Austrian Caucasians and analyzed the results with respect to the Gly16/Arg16 polymorphism. Fifty-seven normotensive men, 20 to 32 years of age with body mass index of 18.7 to 29.9 kg/m2, were genotyped for the Arg16/Gly16 beta-2 AR alleles. All 15 Gly16/Gly16 subjects, all 12 Arg16/Arg/16 subjects, and 27 of 30 heterozygous subjects underwent hemodynamic measurements while supine after an overnight fast. The observers were unaware of the subjects' genotypes. The subjects received a graded infusion of the selective beta-2 AR agonist salbutamol (0.07, 0.14, and 0.21 microgram/kg per minute, respectively), each dose over 8 minutes. Stroke volume and blood pressure were determined continuously by means of impedance cardiography and oscillometry, respectively. The last 4 minutes of each infusion were evaluated statistically. Basal mean blood pressure was higher in the Gly16/Gly16 subjects compared with Arg16/Arg16 subjects (mean+/-SD: 81.6+/-6.14 versus 75.2+/-4.93 mm Hg, P<0.01). Homozygous Gly16 subjects showed a significantly decreased vasodilation during the first dose of salbutamol infusion compared with Arg16/Arg16 subjects (Deltatotal peripheral resistance index -17.9+/-14.4 versus -30. 6+/-8.3%, P<0.01) despite increased sympathetic counterregulation in the Arg16/Arg16 group (Deltaheart rate +16.9+/-7.0% versus +8.6+/-7. 0%, P<0.01; Deltacardiac index +39.5+/-18.5% versus 21.4+/-18.8%, P<0.05). Our results provide additional evidence that the Gly16/Arg16 alleles of the beta-2 AR are intimately related to blood pressure regulation and deserve further studies in the pathogenesis of essential hypertension.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adrenergic beta-Agonists - administration and dosage
-
Adult - administration and dosage
-
Albuterol - administration and dosage
-
Alleles - administration and dosage
-
Arginine - administration and dosage
-
Austria - administration and dosage
-
Blood Pressure - drug effects
-
Body Mass Index - drug effects
-
European Continental Ancestry Group - genetics
-
Genotype - genetics
-
Glycine - genetics
-
Hemodynamic Processes - drug effects
-
Heterozygote - drug effects
-
Humans - drug effects
-
Infusions, Intravenous - drug effects
-
Male - drug effects
-
Polymorphism, Genetic - drug effects
-
Receptors, Adrenergic, beta-2 - genetics
-
Stroke Volume - drug effects
-
Supine Position - drug effects
-
Variation (Genetics) - drug effects
-
Vasodilation - drug effects
- Find related publications in this database (Keywords)
-
Hypertension
-
Essential
-
Molecular Genetics
-
Beta-2 Adrenergic Receptor
-
Arg16/Gly16 Allele
-
Vasodilation
-
Impedance Cardiography